Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Class I · Ongoing
Superpotent Drug
Advertisement
Advertisement
Affected lots / codes — check yours against thisLot # 504950, Exp Date: 09/30/2026.
- Recalling firm
- VITRUVIAS THERAPEUTICS INC, Auburn, AL
- Classification
- Class I (most serious — risk of serious harm)
- Status
- Ongoing
- Quantity
- 1955 bottles
- Distribution
- US Nationwide.
- Recall initiated
- August 21, 2026
- Classified
- September 22, 2026
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0866-2026%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0866-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →